Quantitative Systems Pharmacology Approaches for Immuno‐Oncology: Adding Virtual Patients to the Development Paradigm-Reference-Cited by-同舟云学术

Quantitative Systems Pharmacology Approaches for Immuno‐Oncology: Adding Virtual Patients to the Development Paradigm

Published:2020-08-14 Issue:3 Volume:109 Page:605-618
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Chelliah Vijayalakshmi¹,Lazarou Georgia¹,Bhatnagar Sumit²,Gibbs John P.²,Nijsen Marjoleen²,Ray Avijit²,Stoll Brian²,Thompson R. Adam²,Gulati Abhishek³⁴,Soukharev Serguei³⁴,Yamada Akihiro³⁴,Weddell Jared³⁴,Sayama Hiroyuki³⁴,Oishi Masayo³⁴,Wittemer‐Rump Sabine⁵,Patel Chirag⁵,Niederalt Christoph⁵,Burghaus Rolf⁵,Scheerans Christian⁵,Lippert Jörg⁵,Kabilan Senthil⁶,Kareva Irina⁶,Belousova Natalya⁶,Rolfe Alex⁶,Zutshi Anup⁶,Chenel Marylore⁷,Venezia Filippo⁷,Fouliard Sylvain⁷,Oberwittler Heike⁷,Scholer‐Dahirel Alix⁷,Lelievre Helene⁷,Bottino Dean⁸,Collins Sabrina C.⁸,Nguyen Hoa Q.⁸,Wang Haiqing⁸,Yoneyama Tomoki⁸,Zhu Andy Z.X.⁸,Graaf Piet H.¹,Kierzek Andrzej M.¹

Affiliation:

1. Certara UK Ltd. Sheffield UK

2. Abbvie Inc. North Chicago Illinois USA

3. Astellas Pharma Global Development Inc./Astellas Pharma Inc. Northbrook Illinois USA

4. Astellas Pharma Global Development Inc./Astellas Pharma Inc. Tokyo or Tsukuba‐shi Japan

5. Bayer AG Leverkusen Germany

6. EMD Serono, Merck KGaA Billerica Massachusetts USA

7. Servier Suresnes France

8. Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd. Cambridge Massachusetts USA

Publisher

Wiley

Subject